AN2 Therapeutics, Inc. (ANTX) Misses Q4 EPS by 7c

March 17, 2026 5:03 PM EDT

AN2 Therapeutics, Inc. (NASDAQ: ANTX) reported Q4 EPS of ($0.29), $0.07 worse than the analyst estimate of ($0.22).

For earnings history and earnings-related data on AN2 Therapeutics, Inc. (ANTX) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings, Maynard Um, Mark Zuckerberg, ARK